Sivik Global Healthcare LLC Natera, Inc. Transaction History

Sivik Global Healthcare LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$85.28 - $112.6 $426,400 - $563,000	-5,000 Reduced 14.29%	30,000 $3.25 Million
Q1 2024 Apr 30, 2024	BUY	$59.21 - $92.9 $2.07 Million - $3.25 Million	35,000 New	35,000 $3.2 Million
Q2 2022 Aug 10, 2022	SELL	$28.13 - $44.54 $1.41 Million - $2.23 Million	-50,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$30.32 - $91.33 $758,000 - $2.28 Million	25,000 Added 100.0%	50,000 $2.03 Million
Q4 2021 Feb 08, 2022	BUY	$86.26 - $119.0 $2.16 Million - $2.98 Million	25,000 New	25,000 $2.34 Million
Q1 2021 May 12, 2021	SELL	$91.47 - $124.36 $1.83 Million - $2.49 Million	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $1.33 Million - $2.23 Million	20,000 New	20,000 $1.99 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.